Awareness | Level of anticipation | Willingness to participate in functional cure trial | ||||
---|---|---|---|---|---|---|
Crude OR | Adjusted OR | Crude OR | Adjusted OR | Crude OR | Adjusted OR | |
Age group | ||||||
16–29 | 1.00 | – | 1.00 | 1.00 | 1.00 | – |
30–39 | 1.01 (0.58–1.76) | – | 0.87 (0.50–1.52) | 0.88 (0.50–1.56) | 0.72 (0.25–2.10) | – |
40–49 | 0.74 (0.40–1.36) | – | 1.28 (0.69–2.37) | 1.18 (0.62–2.22) | 1.19 (0.32–4.37) | – |
50 or over | 0.98 (0.53–1.82) | – | 2.34 (1.18–4.61)* | 2.55 (1.28–5.11)** | 0.62 (0.20–1.94) | – |
Education level | ||||||
Secondary or below | 1.00 | – | 1.00 | – | 1.00 | – |
Post-secondary or above | 0.97 (0.62–1.52) | – | 1.10 (0.69–1.74) | – | 1.12 (0.48–2.59) | – |
STI history in the past year | 1.54 (0.97–2.46) | 1.64 (1.00-2.68)* | 1.23 (0.75–1.99) | 1.46 (0.88–2.42) | 9.94 (1.32–74.65)* | 8.16 (1.06–62.77)* |
Sexual activity after HIV diagnosis | 1.60 (1.03–2.50)* | 1.90 (1.14–3.18)* | 1.08 (0.70–1.69) | – | 1.84 (0.82–4.17) | 2.11 (0.87–5.13) |
Engagement in chemsex | 0.82 (0.53–1.27) | – | 1.25 (0.80–1.94) | – | 3.42 (1.25–9.33)* | 2.35 (0.83–6.61) |
CD4 cell count (cells/uL) | ||||||
≥ 500 | 1.00 | 1.00 | 1.00 | – | 1.00 | – |
< 500 | 1.22 (0.80–1.87) | 1.59 (0.97–2.61) | 0.89 (0.58–1.37) | – | 0.80 (0.36–1.78) | – |
About functional cure | ||||||
Awareness | – | – | 0.48 (0.31–0.75)** | 0.47 (0.30–0.74)** | 0.85 (0.38–1.90) | 0.52 (0.21–1.25) |
Anticipation | 0.48 (0.31–0.75)** | 0.46 (0.29–0.72)*** | – | – | 1.74 (0.77–3.93) | – |
Willingness to participate in trial | 0.85 (0.38–1.90) | – | 1.74 (0.77–3.93) | – | – | – |